Chang, Y.-C.; Wu, C.-Z.; Cheng, C.-W.; Chen, J.-S.; Chang, L.-C.
Redrawing Urokinase Receptor (uPAR) Signaling with Cancer Driver Genes for Exploring Possible Anti-Cancer Targets and Drugs. Pharmaceuticals 2023, 16, 1435.
https://doi.org/10.3390/ph16101435
AMA Style
Chang Y-C, Wu C-Z, Cheng C-W, Chen J-S, Chang L-C.
Redrawing Urokinase Receptor (uPAR) Signaling with Cancer Driver Genes for Exploring Possible Anti-Cancer Targets and Drugs. Pharmaceuticals. 2023; 16(10):1435.
https://doi.org/10.3390/ph16101435
Chicago/Turabian Style
Chang, Yu-Ching, Chung-Ze Wu, Chao-Wen Cheng, Jin-Shuen Chen, and Li-Chien Chang.
2023. "Redrawing Urokinase Receptor (uPAR) Signaling with Cancer Driver Genes for Exploring Possible Anti-Cancer Targets and Drugs" Pharmaceuticals 16, no. 10: 1435.
https://doi.org/10.3390/ph16101435
APA Style
Chang, Y.-C., Wu, C.-Z., Cheng, C.-W., Chen, J.-S., & Chang, L.-C.
(2023). Redrawing Urokinase Receptor (uPAR) Signaling with Cancer Driver Genes for Exploring Possible Anti-Cancer Targets and Drugs. Pharmaceuticals, 16(10), 1435.
https://doi.org/10.3390/ph16101435